FDA Strengthens Warnings of Severe Kidney Injuries Caused by Diabetes Medication Invokana

The Food and Drug Administration just issued another Drug Safety Communication alerting doctors and patients about serious health risks associated with several type 2 diabetes medications, including Invokana.

The FDA is strengthening warnings about the risk of serious, acute kidney injuries for patients taking type 2 diabetes medications canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR). Patients taking these drugs have experienced acute kidney injuries. In some cases, patients taking these drugs have experienced total kidney failure.

Patients are advised to seek medical attention immediately if they experience any of the following signs or symptoms while taking Invokana, Invokament, or any other type 2 diabetes medication containing canagliflozin or dapagliflozin:

• Decreased urine
• Swelling in the legs
• Swelling in the feet

Between March of 2013 and October of 2015, the FDA received many confirmable cases of acute kidney injury from patients taking these medications.

To read the entire FDA Drug Safety Communication about Invokana, click here.

If you or a loved one suffered severe injuries or dangerous side effects when taking Invokana or any other medication, call Graves McLain. The Tulsa Oklahoma Drug Injury attorneys of Graves McLain have extensive experience standing up to major drug manufacturers on behalf of our clients.

If you think you may have suffered serious medical problems after taking prescription medication call Graves McLain at 918-359-6600.

When you call, you will speak with one of our experienced Tulsa Drug Injury attorneys absolutely FREE. There is no fee for your consultation, and you owe us nothing unless we recover for you.

At Graves McLain, we will fight hard to protect your rights and recover the maximum compensation you deserve.

Graves McLain – Serious Lawyers for Serious Injuries